ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2069

Proteinase Activated Receptor-4 Stimulation Promotes Leukocyte Adhesion in the Rat Knee Joint

Jason J. McDougall, Departments of Pharmacology and Anaesthesia, Dalhousie University, Halifax, NS, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Animal models, Inflammation, leukocytes and pharmacology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis: Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: Proteinase activated receptors (PARs) are a family of G protein-coupled receptors that signal by enzymatic cleavage of the receptor in a specific extracellular domain. Since PAR-4 has been shown to cause pain and inflammation in synovial joints, the aim of this study was to examine the effect of PAR-4 activation on leukocyte kinetics in the synovial microvasculature.

Methods: Male c57/bl6 mice were deeply anaesthetised and the right knee joint was exposed. An intravenous injection of 0.05% rhodamine was administered to label circulating leukocytes. Intravital microscopy was used to measure leukocyte trafficking in the joint in response to local administration of the PAR-4 agonist AYPGKF-NH2 (50mM). Comparisons were made in wild-type and P-selectin knockout mice. The effect of the PAR-4 antagonist pepducin p4Pal10 on leukocyte kinetics in an adjuvant monoarthritic knee was also assessed.

Results: In wild-type animals, AYPGKF-NH2 caused a gradual increase in leukocyte rolling and adherence which was not present in P-selectin knockout mice (P<0.0001, n=8). Treatment of arthritic mice with pepducin p4Pal10 reduced leukocyte rolling and accumulation in the joint (P<0.0001).

Conclusion: Activation of PAR-4 in rat knee joints causes leukocyte rolling and adhesion that is P-selectin-dependent. In an arthritic joint, blockade of PAR-4 with pepducin p4Pal10 reversed these pro-inflammatory changes indicating that PAR-4 antagonism can have an anti-inflammatory outcome.


Disclosure:

J. J. McDougall,
None;

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/proteinase-activated-receptor-4-stimulation-promotes-leukocyte-adhesion-in-the-rat-knee-joint/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology